Pericapsular Nerve Group (PENG) Block for Hip Fracture; a prospective randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202008763735746

Enrollment

Registered

2020-08-03

Start date

2019-06-24

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perioperative analgesia for hip fracture surgery

Interventions

control group

Pericapsular nerve group block

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: age 18- 70 years either gender ASA I-III elective hip fracture surgery

Exclusion criteria

Exclusion criteria: patient refusal patients with any contraindication to regional anesthesia (e.g. local infection, coagulation abnormality) known allergy to local anesthetics mental disorders drug or alcohol abuse

Design outcomes

Primary

Measure	Time frame
24 h postoperative rescue analgesic consumption	—

Secondary

Measure	Time frame
postoperative VAS score;time to first analgesic request	—

Countries

Egypt

Contacts

Public ContactShaimaa Farouk

lecturer of anesthesia and surgical ICU Faculty of Medicine Tanta University

shaimaafarouk7777@yahoo.com01270440771

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026